Physician profile
Erick Henderson
NPI 1912437872
$265,652.22
in general payments reported to CMS, 2019-2025
25 companies · $47K in 2025
The $47K reported for 2025 was more than what 99% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $47K · 2020: $25K · 2021: $97K · 2022: $34K · 2023: $8,958 · 2024: $7,296 · 2025: $47K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $36K · Consulting Fee: $9,830 · Travel and Lodging: $7,654 · Food and Beverage: $6,189 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,875 · Gift: $4.59.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $35,525.00 |
| Consulting Fee | $9,830.00 |
| Travel and Lodging | $7,653.81 |
| Food and Beverage | $6,189.21 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,875.00 |
| Gift | $4.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $156,602.12 | 2019-2025 | Total30, Rocklatan, Clareon Panoptix Pro |
| Bausch & Lomb Americas INC. | $45,683.33 | 2022-2025 | Miebo, Xiidra, Infuse |
| Valley Contax, INC. | $21,736.53 | 2019-2025 | |
| Allergan, INC. | $20,958.99 | 2019-2022 | |
| Abbvie INC. | $14,397.64 | 2022-2025 | |
| Tarsus Pharmaceuticals, INC. | $1,862.94 | 2024-2025 | Xdemvy |
| Johnson & Johnson Vision Care, INC. | $1,471.45 | 2019-2024 | Acuvue |
| Oyster Point Pharma, INC. | $648.10 | 2022-2025 | Tyrvaya, Ryzumvi |
| Biotissue Holdings INC. | $522.55 | 2022-2025 | |
| Coopervision INC. | $460.89 | 2022-2024 | Myday Contact Lens, Misight Contact Lens |
| Novartis Pharmaceuticals Corporation | $257.09 | 2021-2023 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $222.61 | 2019-2021 | |
| Horizon Therapeutics Plc | $198.44 | 2022-2023 | Tepezza |
| Lkc Technologies, INC. | $150.75 | 2025 | |
| Kala Pharmaceuticals, INC. | $111.82 | 2021-2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $100.03 | 2020-2023 | Cequa |
| Thea Pharma INC. | $54.69 | 2023-2025 | Iyuzeh |
| Dompe US, INC. | $45.85 | 2022-2024 | Oxervate |
| Mallinckrodt Hospital Products INC. | $31.33 | 2025 | Acthar |
| Rxsight INC | $30.50 | 2025 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Contact Lens |
| Abb Con-Cise Optical Group LLC | $24.75 | 2022 | |
| Harrow Eye, LLC | $24.28 | 2024 | Vevye |
| Glaukos Corporation | $22.11 | 2025 | Idosetr |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $14.03 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erick Henderson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.